APA (7th ed.) Citation

AA, A., A, M., AR, A., E, C., A, S., Y, A., . . . I, A. (2020). Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: A Bayesian network meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 28(3), 1031. https://doi.org/10.1007/s00520-019-05210-4

Chicago Style (17th ed.) Citation

AA, Alhifany, et al. "Efficacy of Olanzapine, Neurokinin-1 Receptor Antagonists, and Thalidomide in Combination with Palonosetron Plus Dexamethasone in Preventing Highly Emetogenic Chemotherapy-induced Nausea and Vomiting: A Bayesian Network Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 28, no. 3 (2020): 1031. https://doi.org/10.1007/s00520-019-05210-4.

MLA (9th ed.) Citation

AA, Alhifany, et al. "Efficacy of Olanzapine, Neurokinin-1 Receptor Antagonists, and Thalidomide in Combination with Palonosetron Plus Dexamethasone in Preventing Highly Emetogenic Chemotherapy-induced Nausea and Vomiting: A Bayesian Network Meta-analysis." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 28, no. 3, 2020, p. 1031, https://doi.org/10.1007/s00520-019-05210-4.